Medicine and Surgery SCRIPT module ‘Paediatric Prescribing’ split into two modules

19th June 2024

We have recently split the ‘Paediatric Prescribing’ module in our Medicine and Surgery portfolio into two modules, these are titled ‘Paediatric Practical Prescribing’ and ‘Paediatric Pharmacokinetics’.

Following the introduction of the feedback form at the end of each of our modules, we received quite a bit of feedback relating to the length of the original paediatric module. The two new modules now cover exactly the same content as the original module, but in a more digestible and focused format. The two modules are available in our Medicine and Surgery portfolio. The ‘Paediatric Pharmacokinetics’ module can be found in the Principles of Prescribing category and the ‘Paediatric Practical Prescribing’ module in our Prescribing in Special Circumstances category.

More News

SCRIPT eLearning Shortlisted for Prestigious HSJ Patient Safety Award

SCRIPT eLearning is delighted to announce that it has been shortlisted in the ‘Patient Safety Education and Training’ category of the HSJ Patient Safety Awards 2026, recognising its ongoing contribution to improving safety in prescribing and medicines management. The...

Birmingham Education for Health Professional Conference 2026

The SCRIPT team was delighted to present a poster at the Birmingham Education for Health Professional Conference 2026, led by our Research Associate Divya Singh. The poster, titled "eLearning in Multidisciplinary Prescribing Education: A Longitudinal Evaluation...

New Modules Under Development

We are committed to developing and adding new modules to ensure the SCRIPT programme continues to reflect current clinical practice and meets our learners’ changing needs. We have several modules at various stages of development, including Drugs of Addiction and...

Updated module – Diabetes: Antihyperglycaemic Medicines

NICE has recently updated its guidance on ‘Type 2 diabetes in adults: management’. In a change to national guidance modified‑release metformin alongside an SGLT2 inhibitor is now recommended as first‑line treatment for adults with type 2 diabetes mellitus....